The amount of methanol is not compliant!Huoxiang Zhengqi is recalled, and the main product of Tai Chi Group will be available for the quality black list

On August 29, Tai Chi Group (600129) was trapped again.

The State Drug Administration issued the "State Drug Administration on the Notice of 20 batches of drugs that did not meet the prescribed regulations (2022)", of which Tai Chi Group Sichuan Nanchong Pharmaceutical Co., Ltd., a wholly -owned subsidiary of Tai Chi Group, Huoxiangzhengqi (batch number: 2021013 ,2021046) The detection of methanol quantity does not meet the regulations. On August 30, Nanchong Pharmaceutical recalled all the above batch number products.

As of the close of August 31, the stock price of Tai Chi Group fell 2.83%to 26.07 yuan/share, with a total market value of 14.518 billion yuan.

Recall 15677 Boxing Huoxiang Zhengqi Water

In the above announcement, there are as many as 7 varieties, and 20 batches from 10 manufacturers. Among them, in addition to Nanchong Pharmaceutical, the results of Huoxiang Zhengqi Shui Shui Shui Shui Shui Shui Shui Shui Shui Shui Shui Shui Shui Shui Shui Shui Shui Shui Shui Shui Shui Shui Shui Shui water sampling results also showed that the amount of methanol also showed that the amount of methanol did not meet the regulations.

On August 30, Tai Chi Group announced that, in accordance with the principles of responsibility for consumers, Nanchong Pharmaceutical's 15677 boxes were recalled by the procedures for the unpaid part of the above batch number products, and Tai Chi Group had a sincere apology on the adverse effects of the incident.

It is worth noting that there are many types of Huoxiangzhengqi dosage type. The regular dosage forms of the hospital are soft capsules and co -agents, and the retail end is a preparation, apipes and dripping pills.

The so-called "can drink" Huoxiang Zhengqi is not alcoholic. The Huoxiang Zhengqi water involved this time is a pyrine, which contains 40%-50%of alcohol.

It is reported that the amount of methanol reflects the content of methanol that may be brought by ethanol in ethanol preparations such as alcohol or pyrine. "China Pharmacopoeia" (2020) stipulates that in addition to other regulations, the amount of methanol for test liquid must not exceed 0.05%(ML/ML).

Industry insiders revealed that in food, there may be adulteration of alcoholic beverages, which means that methanol instead of ethanol, or causing food poisoning. The exception of methanol will affect the human nervous system, and a typical serious harm is to cause blindness.

Tai Chi Group then said that among the companies and subsidiaries of Huoxiang Zhengqi, only Nanchong Pharmaceuticals produced and sold. According to the financial report data, in 2021, the sales revenue of Huoxiangzhengqi water produced by Nanchong Pharmaceutical was 6.65 million yuan, accounting for 0.05%of Tai Chi Group's operating income of 2021; The proportion is very small and has no significant impact on the company's production and operation.

It is worth noting that this is the second time that the company's production drugs have been notified for the second time in the past month. On July 29, the drug spot inspection and inspection information released by the Guangdong Pharmaceutical Supervision Bureau showed that the penicillin V potassium tablets (batch number: 2011103) produced by the Tai Chi Group Holding subsidiary Southwest Pharmaceutical Co., Ltd. was unqualified.

"Fairy Formula" in Chinese medicine -Huoxiang Zhengqi is popular

As a well -known OTC category, Huoxiang Zhengqi has long been competitive in retail channels. According to the data of Zhongkang CHIS Kaishi System, Huoxiang Zhengqi in 2021 was about 2.473 billion yuan in market sales, ranking second in the retail channel cold and heat -clearing drugs.

According to the 2020 edition of the "Pharmacopoeia of the People's Republic of China", the ingredients of Huoxiangzhengqi include the ingredients, Chenpi, Hipu, Baiyan, Poria, Big Beauty, Summer, licorice extract, patchouli sesame oil, perilla leaf oil and so on. It has the effects of relieving dampness, stomach vomiting, and aroma.

The "Fairy Formula", known as the Chinese medicine, has become popular rapidly under high temperature weather this year. Recently, a trend of "Huoxiang Zhengqi Bingzhong" has also been scratched.

The so -called "Huoxiangzhengqi Ice Chinese" is actually adding Huoxiangzheng Qi liquid to the water with ice cubes, similar to American coffee, but only replaced the coffee with Huoxiang Zhengqi water. What's more, the Huoxiang Zhengqi liquid is directly added to the ice American style in order to neutralize the taste of coffee and Huoxiang Zhengqi, and at the same time, it can achieve the effect of waking brain and clearing heat.

After the "formula" became popular, netizens rushed to imitate, and even called "Huoxiang Zhengqi Bing Chinese" the best limited -limited drink in the summer of 2022.

In fact, Tai Chi Group has a unique trend in the Huoxiang Zhengqi market and has absolute industry voice. According to the data of Zhongkang Chis Kaishi System, the market share in 2021 is as high as 58%, especially in the proportion of retail channels, as high as 92%.

Relying on this "demon style", although Huoxiang Zhengqi water of this "accident" was recalled, compared with the smaller sales share of such products, the "Huoxiangzheng Qi Oral Oral Liquid" of Tai Chi Group's core products has been Selling nearly 1 billion yuan. Tai Chi Group's semi -annual report in 2022 shows that the sales revenue of Huoxiangzhengqi Oral Overseas Anti -Oral solution was 998 million yuan, an increase of 79%year -on -year, accounting for 21.9%of the company's total revenue of 4.549 billion yuan in pharmaceutical industry.

Tai Chi Group supported by the golden single product

On the evening of August 25, Tai Chi Group released the 2022 semi -annual report, with a record high in the first half of the year. From January to June this year, the company realized operating income of 7.185 billion yuan, an increase of 11.52%year-on-year; Tai Chi Group achieved a net profit of 124 million yuan in shareholders of listed companies, an increase of 61.40%year-on-year; The profit was 179 million yuan, an increase of 112.48%, and the basic earnings per share were 0.22 yuan.

From the perspective of categories, anti -infection drugs (represented by Yibao Shuling), respiratory system (represented by syrup), digestive system (represented by Huoxiangzheng Qi Oral Oral Liquid), nervous system Representatives) The four core categories realized revenue of 948 million yuan, 786 million yuan, 1.204 billion yuan, and 606 million yuan, respectively, an increase of 25.27%, 70.97%, 66.07%, and 37.77%year -on -year. According to Tai Chi Group, in the ranking of China's over -the -counter drug products in 2021, Huoxiang Zhengqi Oral Oral Liquid was the first in the "Chinese Academy · Cold and Summer Wet" and the title of "2021 China African -prescription Pharmaceutical Gold Single Product".

In fact, Huoxiang Zhengqi oral liquid is definitely a "ace item". If it only rely on core products to drive the sales of other products, this road is by no means a long -term plan.

(Tai Chi Group's official website shows the main product)

The official website of Tai Chi Group shows that one of the members of the "Fortune 500" China Pharmaceutical Group Co., Ltd.. It has 13 pharmaceutical factories, more than 20 pharmaceutical business companies, two major R & D institutions, and more than 3,000 chain pharmacy with Sichuan -Chongqing -based positions. Employees have 14,000 people.

At the same time, in recent years, Tai Chi Group's product problems have been continuous and criticized.

In 2016, the "Pediatric Cough Sweet Granules" was identified as inferior drugs after being sampled; the same year, the orange red pill was detected to be higher in sulfur content; in 2017, the "Dragon Dragon Lifting Liver Tablets" was sampled as an unqualified product; in 2020, " Xuanli Luo Wan "was sampling as a unqualified product.

Industry insiders believe that as a pharmaceutical company with a revenue of over 10 billion, it has repeatedly appeared on the quality black list or has little direct relationship with the company's R & D investment.

Open source Securities Research Report pointed out that the company should be committed to strengthening brand building, continuous optimization of categories, and expanding sales channels in the second half of 2022, in terms of category optimization, improve the sales of exclusive products and high -gross products, reduce product structural risks ; Targeted diseases, multiple diseases, and chronic patients provide Tai Chi full varieties solutions to create special categories; complete the listing of new varieties of annual planning, add new channels for new product regulations; model.

Edit | He Menglu School Inspection | Yuan Steel Review | Liao Xiaotao

- END -